Should Patients Receiving ACE Inhibitors or Angiotensin Receptor Blockers be Switched to Other Antihypertensive Drugs to Prevent or Improve Prognosis of Novel Coronavirus Disease 2019 (COVID-19)?
the Italian Society of Pharmacology, Gianluca Trifirò, Salvatore Crisafulli, Giuseppe Andò, Giorgio Racagni, Filippo Drago
Topics & Concepts
MedicineCoronavirus disease 2019 (COVID-19)Angiotensin Receptor BlockersPharmacologySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakCoronavirusACE inhibitorAngiotensin-converting enzymeInternal medicineDiseaseVirologyInfectious disease (medical specialty)Blood pressureOutbreakBlood Pressure and Hypertension StudiesCOVID-19 Clinical Research StudiesHeart Rate Variability and Autonomic Control